Cuproptosis: Advances in Stimulus‐Responsive Nanomaterials for Cancer Therapy
Advanced Healthcare Materials · 2024-07 · 13 (19)
DOI: 10.1002/adhm.202400652 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.04.2024. Verfasst von Jiacheng Lu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials and Chemistry, Institute of Bismuth Science, Shanghai Collaborative Innovation Center of Energy Therapy for Tumors, University of…. Hauptthemen laut MEDLINE: Neoplasms, Nanostructures, Copper. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: Shanghai Key Laboratory of Molecular Imaging, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Cuproptosis, a recently identified non‐apoptotic programmed cell death modality, attracts considerable attention in the realm of cancer therapeutics owing to its unique cellular demise mechanisms. Since its initial report in 2022, strategies inducing or amplifying cuproptosis for cancer treatment emerge. The engineering of nano‐systems to elicit cuproptosis effectively circumvents constraints associated with conventional small‐molecule pharmaceutical interventions, presenting novel prospects for oncological therapy. Stimulus‐responsive nanomaterials, leveraging their distinctive spatiotemporal control attributes, are investigated for their role in modulating the induction or augmentation of cuproptosis. In this comprehensive review, the physiological characteristics of cuproptosis, encompassing facets such as copper overload and depletion, coupled with regulatory factors intrinsic to cuproptosis, are expounded upon. Subsequently, design methodologies for stimulus‐responsive induction or enhancement of cuproptosis, employing stimuli such as light, ultrasound, X‐ray, and the tumor microenvironment, are systematically delineated. This review encompasses intricacies in nanomaterial design, insights into the therapeutic processes, and the associated advantages. Finally, challenges inherent in stimulus‐responsive induction/enhancement of cuproptosis are deliberated upon and prospective insights into the future trajectory of copper‐mediated cancer therapy are provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials and Chemistry, Institute of Bismuth Science, Shanghai Collaborative Innovation Center of Energy Therapy for Tumors, University of Shanghai for Science and Technology, Shanghai, 200093, China.
ORCID-Profile: Yuhao Li
Förderung
- Shanghai Key Laboratory of Molecular Imaging
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Lu, J., Miao, Y., & Li, Y. (2024). Cuproptosis: Advances in Stimulus‐Responsive Nanomaterials for Cancer Therapy. Advanced Healthcare Materials, 13(19). https://doi.org/10.1002/adhm.202400652
Vancouver
Lu J, Miao Y, Li Y. Cuproptosis: Advances in Stimulus‐Responsive Nanomaterials for Cancer Therapy. Advanced Healthcare Materials. 2024;13(19). doi:10.1002/adhm.202400652
BibTeX
@article{Lu2024,
author = {Lu, Jiacheng and Miao, Yuqing and Li, Yuhao},
title = {Cuproptosis: Advances in Stimulus‐Responsive Nanomaterials for Cancer Therapy},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {19},
doi = {10.1002/adhm.202400652}
}
EUVIMED